Wennogle, Lawrence P.,Fienberg, Allen A.,Mates, Sharon
申请号：
AU2009251816
公开号：
AU2009251816B2
申请日:
2009.05.27
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
Use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals and pharmaceutical compositions comprising them for the treatment of one or more disorders involving the 5-HT2A, SERT and/or dopamine D2 pathways are disclosed. In addition, the compounds may be combined with other therapeutic agents for the treatment of one or more sleep disorders, depression, psychosis, dyskinesias, and/or Parkinson's disease or any combinations.
